StockData

Galderma Group AG (GALDY) shareholders

GALDYOTCFiscal year ends December 31Also trades as GDERF
$41.92−0.55 (-1.30%)

Close on Oct 19, 2026Market cap –P/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
0M
Shares held, 13F filers
Institutional holders
5
2 new, 0 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of GALDYValueChange% of portfolio
Rhumbline Advisers30,607–$1.39M+6,6650.00%
PNC Financial Services Group, Inc.3,224–$146.60K+1,1850.00%
GAMMA Investing LLC1,270–$57.75KNew0.00%
Salomon & Ludwin, LLC789–$34.85K−2570.00%
IMA Wealth, Inc.268–$12.19KNew0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares heldNew / addedReduced / closedShares boughtShares sold
Q2 202650M2 / 21 / 00M0M
Q1 202630M0 / 30 / 10M0M
Q4 202540M2 / 20 / 00M0M
Q3 202520M2 / 00 / 00M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

4 funds held GALDY in Q2 2026, 28% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of GALDYValue% of fundAs of
iShares Flexible Equity Active ETF1,057,404–$46.10M2.87%Jul 31, 2026
ActivePassive International Equity ETF39,834–$1.70M0.16%May 31, 2026
One Global ETF18,396–$783.85K0.76%May 31, 2026
John Hancock Hedged Equity ETF8,059–$366.44K0.41%Jun 30, 2026
NPF Core Equity ETF219–$9.55K0.00%Jul 31, 2026

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
-57.5%
From 0M shares
Short volume, 0 days
–
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Galderma's stock actually held short. Settlement fails (shares not delivered on time) peaked at 38,007 shares on Oct 13, 2026 over the last 90 days.

See a number that looks wrong?